Minntech's Hemodialysis Concentrate Manufacturing System to Debut at ANNA 2000.Business Editors MINNEAPOLIS--(BUSINESS WIRE)--April 7, 2000 Minntech Corporation (Nasdaq: MNTX), a worldwide leader in hemodialysis products and services, today announced the introduction of the Renapak 2(TM) Concentrate Manufacturing System. The Renapak 2(TM), which will be exhibited at the 31st Annual National Symposium of the American Nephrology nephrology Branch of medicine dealing with kidney function and diseases. An understanding of kidney physiology is important not only in treating kidney disease but in knowing the effect of drugs, diet, and hypertension on kidney disease, and vice versa. Nursing Association in Nashville, TN (April 9-12, 2000), provides dialysis clinics with an innovative, quality-conscious method of producing their own hemodialysis concentrates. Hemodialysis concentrates are mixed with purified water Purified water can come from any source, including spring water, well water, seawater, or municipal water. This source water is then processed by reverse osmosis or deionization to produce a water that is indistinguishable from distilled water from any other source. to make dialysate dialysate /di·al·y·sate/ (di-al´i-sat) the fluid and solutes in a dialysis process that flow through the dialyzer, do not pass through the membrane, and are discarded along with removed toxic substances after leaving the dialyzer. , a fluid used in hemodialysis treatments to both nourish and clean the bloodstream by drawing toxins out and replacing kidney-regulated chemicals and electrolytes. These concentrates are sold in powder or liquid form. "Hemodialysis clinics operate in an extremely cost-contained environment," said Marlin Rudebusch, Marketing Director of Minntech Renal Systems Division. "Freight and shipping charges and required storage space for pre-mixed dialysate concentrate can add significantly to treatment costs. With the Renapak 2(TM) system, customers can easily and economically produce high-quality concentrates, when they need them, in less than 30 minutes." Minntech offers a full line of pre-measured powdered sodium acetate and bicarbonate concentrate formulas for use with the Renapak 2(TM) system. Each bag of U.S.P. (United States Pharmacopeia United States Pharmacopeia /Unit·ed States Phar·ma·co·peia/ (USP) a legally recognized compendium of standards for drugs, published by The United States Pharmacopeial Convention, Inc., and revised periodically. ) grade powder weighs less than 20 pounds for ease of handling and mixing. A unique labeling system allows users to "peel-and-stick" powder package labels directly into the provided Renapak "Master Record" for an efficient visual record suitable for documentation purposes. "Minntech has been a market leader in hemodialysis concentrates since the Company was founded over 25 years ago," added Thomas J. McGoldrick, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "Minntech is also known for its innovative service and product customer solutions in the dialysis community. The Renapak 2(TM) certainly lives up to that reputation, and we are pleased to offer healthcare providers with yet another tool for providing quality and cost effective renal care." The market introduction of the Renapak 2(TM) system is the latest in a series of strategic initiatives designed to build and capitalize on Minntech's expertise in the dialysis market. In November, the Company opened its first dialyzer dialyzer /di·a·lyz·er/ (di´ah-liz?er) hemodialyzer. di·a·lyz·er n. 1. A machine equipped with a semipermeable membrane and used for performing dialysis. 2. reprocessing Reprocessing may refer to:
Any surgical procedure intended to end fertility permanently (see contraception). Such operations remove or interrupt the anatomical pathways through which the cells involved in fertilization travel (see reproductive system). , and documentation. Since its opening, the facility has completed over 12,000 reprocessing cycles for area dialysis centers, and has been well-received by the dialysis community. Minntech plans to open additional reprocessing centers in other cities over the next 12 to 18 months, all equipped with the Company's market-leading Renatron(R) II Automated Dialyzer Reprocessing System, RenaClear(TM) Dialyzer Cleaning System, and Renalin(R) Cold Sterilant sterilant a sterilizing agent, i.e. an agent that destroys microorganisms. . Minntech Corporation is a provider of products and services for the dialysis, medical device reprocessing, and filtration and separation markets. The Company's product portfolio and business development strategies focus on the strengths of its advanced proprietary technologies in hollow fibers, automated disinfection disinfection, n the process of destroying pathogenic organisms or rendering them inert. disinfection, full oral cavity, n a procedure used to reduce active periodontal disease, usually completed within a certain short time frame. and sterilization systems, and sterilants. To learn more, visit Minntech online at www.minntech.com. This news release contains forward-looking statements which involve risks and uncertainties. The company's actual results could differ materially from those in any such forward-looking statements. Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended March 31, 1999 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion